India Approves First Dengue Vaccine QDENGA as DCGI Grants Market Authorisation to Takeda Vaccine

India Approves First Dengue Vaccine QDENGA as DCGI Grants Market Authorisation to Takeda Vaccine

:India approves its first dengue vaccine QDENGA after the Drug Controller General of India grants market authorisation to Takeda Biopharmaceuticals India. The vaccine is approved for people aged 4 to 60 years and aims to strengthen India’s fight against the growing dengue burden.

India has approved its first dengue vaccine, marking a significant development in the country’s ongoing efforts to combat one of the world’s most widespread mosquito-borne diseases. The Drug Controller General of India (DCGI) has granted market authorisation to QDENGA, a dengue vaccine developed by Takeda Biopharmaceuticals India.

According to Takeda, the approval represents a major milestone in India’s fight against dengue, a disease that affects millions of people every year and continues to pose a serious public health challenge across the country.

The vaccine has been approved for individuals aged 4 to 60 years and can be administered regardless of whether a person has previously been infected with dengue. Unlike some existing dengue vaccines, QDENGA does not require pre-vaccination screening, allowing eligible individuals to receive the vaccine without undergoing prior testing for past dengue infection.

The approval comes at a time when India continues to experience one of the world’s highest dengue burdens. Dengue cases have increased sharply over the past two decades due to factors including urbanisation, climate change, changing mosquito habitats and population growth.

Read More India Approves First Dengue Vaccine as Takeda’s QDENGA Receives Market Authorization for Ages 4-60

QDENGA is a live-attenuated tetravalent vaccine designed to provide protection against all four dengue virus serotypes, including DENV-1, DENV-2, DENV-3 and DENV-4. The vaccine has already received approval in more than 40 countries, including the European Union, the United Kingdom, Brazil, Indonesia and Argentina.

Read More Delhi Protests Intensify as Clashes Erupt at Jantar Mantar Over NEET-UG 2026 Paper Leak Crisis

With this approval, India has joined the group of countries using QDENGA as dengue continues to emerge as one of the country’s major seasonal public health threats. Takeda stated that QDENGA has also received World Health Organization prequalification, confirming that it meets international standards for quality, safety and effectiveness.

Read More Indian Army Rescues 571 People in Flood-Hit Upper Assam Under Operation Jal Rahat

The World Health Organization prequalification also makes the vaccine eligible for procurement by global agencies such as UNICEF and the Pan American Health Organization.

Dengue is a mosquito-borne viral disease that presents a significant global public health challenge, with prevalence reported across more than 125 countries. India accounts for nearly one-third of the global dengue burden, making the approval of QDENGA a major step in strengthening preventive healthcare measures against the disease.

 

Tags:

About The Author

Post Comment

Comment List

Latest News

Live Cricket Score

Advertisement

Science & Tech

Elon Musk Predicts AI Dominance, Robotic Surgeons, and Longer Human Lifespans by the End of the Decade Elon Musk Predicts AI Dominance, Robotic Surgeons, and Longer Human Lifespans by the End of the Decade
Elon Musk predicts major breakthroughs in AI, robotics, human longevity, and automated labor, claiming robots could surpass human surgeons within...
Skyroot Aerospace Set to Launch India's First Private Orbital Rocket in Historic Space Milestone

Health

Coffee-Based Home Remedies Gain Ground as Dermatologists Highlight Natural Skincare Benefits Coffee-Based Home Remedies Gain Ground as Dermatologists Highlight Natural Skincare Benefits
A growing number of dermatologists are endorsing coffee-based home remedies as natural, affordable alternatives to commercial skincare. From face scrubs...
Moringa’s Rise as a Global Superfood Gains Momentum Amid New Research

Lifestyle

 Food Pharmer Sparks Nationwide Debate Over Cheeslings Ingredients, Raises Questions on Food Safety Standards Food Pharmer Sparks Nationwide Debate Over Cheeslings Ingredients, Raises Questions on Food Safety Standards
Food influencer Revant Himatsingka, known as Food Pharmer, has sparked nationwide debate after revealing Cheeslings’ low cheese content and high...
From Gym Floor to City Streets: The Unexpected Revival of the Lopifit Treadmill-Bike
crossorigin="anonymous">